A study using an OVA-induced asthma mice model showed that the treatment with EGFR or Src inhibitor improved allergic airway inflammation represented as inflammatory cells in broncho alveolar lavage fluid (BALF), peribronchial inflammation, airway remodeling, and AHR in the same degree [19]. This evidence concerns the gene EGFR and asthma.